Sghealthcare에스지헬스케어
398120 · KOSDAQ · ₩398120 · 에스지헬스케어
₩2,040▼ ₩120 (5.56%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Revenue | ₩4.2B | ₩4.9B | ₩12B | ₩5.1B | ₩4.1B | ₩3.7B |
| Cost of sales | ₩2.9B | ₩3.1B | ₩7.9B | ₩3.8B | ₩3B | ₩2.7B |
| Gross profit | ₩1.3B | ₩1.9B | ₩3.8B | ₩1.3B | ₩1.1B | ₩964M |
| Operating income | −₩751M | ₩162M | ₩2.1B | ₩96M | −₩444M | −₩290M |
| Net income | −₩692M | ₩24M | ₩869M | ₩432M | ₩38M | −₩403M |
| Net income to shareholders | −₩637M | ₩28M | ₩1.7B | ₩37M | −₩373M | −₩401M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Total assets | ₩39B | ₩39B | ₩41B | ₩38B | ₩31B | ₩32B |
| Current assets | ₩25B | ₩25B | ₩27B | ₩25B | ₩19B | ₩20B |
| Cash and equivalents | ₩4.9B | ₩3.7B | ₩2.1B | ₩2.3B | ₩1.9B | ₩4.7B |
| Total liabilities | ₩13B | ₩13B | ₩16B | ₩16B | ₩9.3B | ₩9.6B |
| Current liabilities | ₩13B | ₩13B | ₩15B | ₩15B | ₩8.7B | ₩5.1B |
| Borrowings | ₩7.5B | ₩7.5B | ₩8.5B | ₩8.5B | ₩6.5B | ₩6.4B |
| Total equity | ₩25B | ₩26B | ₩24B | ₩22B | ₩22B | ₩22B |
| Shareholders' equity | ₩25B | ₩25B | ₩24B | ₩22B | ₩22B | ₩22B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Cash from operations | ₩1.3B | ₩1.8B | −₩921M | ₩81M | −₩1.9B | −₩1.5B |
| Free cash flow | ₩1.3B | ₩1.8B | −₩921M | ₩81M | −₩1.9B | −₩1.5B |
Consolidated where available. Amounts in won.
Also known as: Sghealthcare / 에스지헬스케어 / 398120 / KRX:398120
Source: KRX statistical information